NEJM conducts independent market research to track physicians’ reading and prescribing habits and makes this information available to advertisers free of charge.
These independent studies are available to advertisers.
Essential Journal Study
The 2017 Essential Journal Study is the latest in a unique series of studies conducted among internists and internal medicine subspecialists. It is an indispensable tool for pharmaceutical marketers, as it identifies the “must-read” journals physicians consider essential to their practice.
NEJM also subscribes to Kantar Media.